Old College Capital logo

Old College Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

7

Common Fundraising Type

Seed

Concinnity logo
Concinnity

Biotech

Eos Advisory logo
Scottish Enterprise logo
Old College Capital logo
Maven Capital Partners logo

Concinnity is a biotech company that uses AI-driven RNA-based systems to enhance the safety of gene therapies.

Seed
$3.8M
12/16/2024
Article
Cytomos logo
Cytomos

Biotechnology

Archangels logo
Scottish Enterprise logo
Old College Capital logo
British Business Bank logo

Cytomos is a biotechnology company that develops scalable cell-analysis technology to provide cost-effective solutions for biopharma companies.

Equity
$6.3M
11/19/2024
Article
Invizius logo
Invizius

Biotech

Mercia Ventures logo
University of Edinburgh logo
Syensqo logo
Scottish Enterprise logo
Calculus Capital logo

Invizius is a biotech company developing H-Guard, a product designed to reduce inflammatory responses in dialysis and ICU patients undergoing continuous renal replacement therapy.

Equity
$1.3M
09/24/2024
Article
Neuranics logo
Neuranics

Health Tech

Par Equity logo
Old College Capital logo
GU Holdings logo
Creator Fund logo

Neuranics develops magnetic sensors integrated with semiconductor technology for health, fitness, and metaverse applications, aiming to improve health monitoring devices and human-machine interfaces.

Equity
$2.3M
10/11/2023
Article
Neuranics logo
Neuranics

Health Tech

Par Equity logo
Old College Capital logo
GU Holdings logo
Creator Fund logo

Neuranics develops magnetic sensors integrated with semiconductor technology for health, fitness, and metaverse applications, aiming to improve health monitoring devices and human-machine interfaces.

Seed
$2.3M
09/28/2023
Article
AlveoGene logo
AlveoGene

Gene Therapy

University of Edinburgh logo
Oxford Science Enterprises logo
Harrington Discovery Institute at University Hospitals logo

AlveoGene is a UK-based biotech company that develops inhaled gene therapies for rare respiratory diseases, with an initial focus on alpha-1 antitrypsin deficiency disease.

Seed
Undisclosed
09/14/2023
Article
AlveoGene logo
AlveoGene

Gene Therapy

University of Edinburgh logo
Oxford Science Enterprises logo
Harrington Discovery Institute at University Hospitals logo

AlveoGene is a UK-based biotech company that develops inhaled gene therapies for rare respiratory diseases, with an initial focus on alpha-1 antitrypsin deficiency disease.

Seed
Undisclosed
09/14/2023
Article